Apyx Medical Corporation (APYX)

Market Cap	62.97M
Revenue (ttm)	48.72M
Net Income (ttm)	-19.14M
Shares Out	34.57M
EPS (ttm)	-0.47
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	195,278
Open	1.9
Previous Close	1.82
Day's Range	1.77 - 1.9
52-Week Range	1.31 - 14.51
Beta	1.52
Analysts	Buy
Price Target	9.18 (+390.9%)
Earnings Date	Nov 10, 2022

About APYX

Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium to cut, coagulate and ablate soft tissue during open and laparoscopic surgical procedures. The company offers Renuvion branded products for the cosmetic surgery market that enable plastic surgeons, fascial plastic surgeons, and...

• Industry: Health Care Equipment & Supplies
• IPO Date: Jan 1, 1987
• CEO: Robert Gershon
• Employees: 272
• Stock Exchange: NASDAQ
• Ticker Symbol: APYX

Financial Performance

In 2021, Apyx Medical's revenue was $48.52 million, an increase of 75.08% compared to the previous year's $27.71 million. Losses were -$15.17 million, 27.5% more than in 2020.

Analyst Forecast

According to 10 analysts, the average rating for APYX stock is "Buy." The 12-month stock price forecast is 9.18, which is an increase of 390.91% from the latest price.

Price Target

$9.18

(390.91% upside)

Analyst Consensus: Buy